Analyst Downgrades – NYSE:ABBV – AbbVie (NYSE:ABBV) Stock Gets Downgraded By Goldman Sachs Group from Conviction-Buy ➝ Buy to

ME Staff
-
0

Analyst Ratings For NYSE:ABBV – AbbVie (NYSE:ABBV)

Today, NYSE:ABBV – AbbVie (NYSE:ABBV) stock was downgraded by Goldman Sachs Group from Conviction-Buy ➝ Buy to .

Some recent analyst ratings include

  • 5/24/2018-Goldman Sachs Group was Downgraded by analysts at Goldman Sachs Group from a “Conviction-Buy ➝ Buy” rating to a “” rating.

Dividend information for NYSE:ABBV – AbbVie (NYSE:ABBV)

NYSE:ABBV – AbbVie (NYSE:ABBV) pays an annual dividend of $3.84 with a yield of 3.72% and an average dividend growth of 15.50% based on a 3 Year Average..

Dividend History for NYSE:ABBV – AbbVie (NYSE:ABBV)

  • On 2/15/2018 NYSE:ABBV – AbbVie announced a quarterly dividend of $0.96 3.36252189141856% with an ex dividend date of 4/12/2018 which will be payable on 5/15/2018.
  • On 10/27/2017 NYSE:ABBV – AbbVie announced a Quarterly dividend of $0.71 3.12% with an ex dividend date of 1/11/2018 which will be payable on 2/15/2018.
  • On 9/8/2017 NYSE:ABBV – AbbVie announced a Quarterly dividend of $0.64 2.94% with an ex dividend date of 10/12/2017 which will be payable on 11/15/2017.
  • On 6/23/2017 NYSE:ABBV – AbbVie announced a quarterly dividend of $0.64 3.52% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
  • On 2/17/2017 NYSE:ABBV – AbbVie announced a quarterly dividend of $0.64 4.14% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
  • On 10/28/2016 NYSE:ABBV – AbbVie announced a quarterly dividend of $0.64 4.44% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
  • On 9/12/2016 NYSE:ABBV – AbbVie announced a quarterly dividend of $0.57 3.56% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.

Recent Insider Trading Activity For NYSE:ABBV – AbbVie (NYSE:ABBV)
NYSE:ABBV – AbbVie (NYSE:ABBV) has insider ownership of 0.07% and institutional ownership of 69.48%.

  • On 3/1/2018 Carlos Alban, EVP, sold 83,574 with an average share price of $114.49 per share and the total transaction amounting to $9,568,387.26.
  • On 3/1/2018 Laura J Schumacher, Insider, sold 25,000 with an average share price of $117.85 per share and the total transaction amounting to $2,946,250.00.
  • On 3/1/2018 William J Chase, CFO, sold 70,928 with an average share price of $117.18 per share and the total transaction amounting to $8,311,343.04.
  • On 2/28/2018 Richard A Gonzalez, Chairman, sold 8,280 with an average share price of $117.88 per share and the total transaction amounting to $976,046.40.
  • On 2/28/2018 Robert A Michael, VP, sold 4,294 with an average share price of $119.43 per share and the total transaction amounting to $512,832.42.
  • On 2/28/2018 Timothy J Richmond, SVP, sold 18,129 with an average share price of $118.67 per share and the total transaction amounting to $2,151,368.43.
  • On 2/20/2018 Robert A Michael, VP, sold 992 with an average share price of $120.31 per share and the total transaction amounting to $119,347.52.

Recent Trading Activity for NYSE:ABBV – AbbVie (NYSE:ABBV)
Shares of NYSE:ABBV – AbbVie closed the previous trading session at 103.19 down -2.41 2.28% with shares trading hands.